Replies to post #2298 on Momenta Pharmaceuticals, Inc. (MNTA)

[investorgold2002]

Dew, I respectfully disagree.

If I were running this business the Incentive for getting Marketing Approval for Copaxone would have been structured like this

Marketing approval before March 2012 - 300K shares
Marketing approval before March 2013 - 200K shares
Marketing approval before March 2015 - 100K shares

Currently, the only incentive to get this approval done as quickly as possible before 2015 is the immediate vesting of half of the shares on approval date.

The only reason I can think of is maybe FDA is years away from really approving this very complex drug.

My guess is copaxone is nowhere near approval before 2013 ??